# Pulse Biosciences, Inc. (PLSE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PLSE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 835.0K | $ -43.24M | $ -33.43M | $ 6.77M | $ 99.50M |
| 2025 | $ 358.4K | $ -74.52M | $ -55.74M | $ 7.53M | $ 80.66M |
| 2024 | $ 0 | $ -56.32M | $ -38.33M | $ 8.90M | $ 114.86M |
| 2023 | $ 0 | $ -45.64M | $ -35.85M | $ 9.14M | $ 44.36M |
| 2022 | $ 782.0K | $ -65.36M | $ -52.97M | $ 75.96M | $ -2.25M |
| 2021 | $ 1.69M | $ -75.67M | $ -64.82M | $ 11.25M | $ 35.69M |
| 2020 | $ 0 | $ -63.51M | $ -45.61M | $ 11.36M | $ 22.89M |
| 2019 | $ 0 | $ -60.63M | $ -44.91M | $ 6.72M | $ 30.74M |
| 2018 | $ 0 | $ -49.59M | $ -31.92M | $ 0 | $ 66.33M |
| 2017 | $ 0 | $ -34.44M | $ -18.37M | $ 0 | $ 46.00M |
| 2016 | $ 0 | $ -13.10M | $ -11.08M | $ 0 | $ 25.30M |
| 2015 | $ 0 | $ -3.95M | $ -4.78M | $ 0 | $ 13.67M |
| 2014 | $ 0 | $ -511.9K | $ -358.0K | $ 0 | $ 16.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.16 |
| Current Ratio | 9.63 |

## Other views

- [Metrics](https://sponda.capital/en/PLSE.md)
- [Charts](https://sponda.capital/en/PLSE/charts.md)
- [Compare](https://sponda.capital/en/PLSE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.